Pharmacotherapy strategies in chronic prostatitis/chronic pelvic pain syndrome management

Bibliography

• Skerk V, Roglic S, Cajic V, Comparison of clinical symptoms scored according to the National Institutes of Health chronic prostatitis symptoms index and assessment of antimicrobial treatment in patients with chronic prostatitis syndrome. J Chemother 2009;21(2):181-7
   Google Scholar
• Nickel JC, Downey J, Hunter D, Clark J. Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index. J Urol 2001;165(3):842-5
   Google Scholar
• de la Rosette JJ, Hubregtse MR, Meuleman EJ, Diagnosis and treatment of 409 patients with prostatitis syndromes. Urology 1993;41(4):301-7
   Google Scholar
• Schaeffer AJ, Darras FS. The efficacy of norfloxacin in the treatment of chronic bacterial prostatitis refractory to trimethoprim-sulfamethoxazole and/or carbenicillin. J Urol 1990;144(3):690-3
   Google Scholar
• Pust RA, Ackenheil-Koppe HR, Gilbert P, Weidner W. Clinical efficacy of ofloxacin (tarivid) in patients with chronic bacterial prostatitis: preliminary results. J Chemother 1989;1(4 Suppl):869-71
   Google Scholar
• Schaeffer AJ. Clinical practice. Chronic prostatitis and the chronic pelvic pain syndrome. N Engl J Med 2006;355(16):1690-8
   Google Scholar
• Walz J, Perrotte P, Hutterer G, Impact of chronic prostatitis-like symptoms on the quality of life in a large group of men. BJU Int 2007;100(6):1307-11
   Google Scholar
• Nickel JC. Treatment of chronic prostatitis/chronic pelvic pain syndrome. Int J Antimicrob Agents 2008;31(Suppl 1):S112-6
   Google Scholar
• Schaeffer A, Anderson R, Krieger J. The assessment and management of male pelvic pain syndrome, including prostatitis. In: McConnell J, Abrams P, Denis L, editors, Male lower urinary tract dysfunction, evaluation and management. 6th International Consultation on New Developments in Prostate Cancer and Prostate Disease. Health Publications, Paris; 2006. p. 341-85
   Google Scholar
• Zhu QF, Xie H, Weng ZL, Detection of bacterial signal of 16S rRNA gene in prostate tissues obtained by perineal approach from patient with chronic pelvic pain syndrome. Zhonghua Yi Xue Za Zhi 2009;89(12):823-5
   Google Scholar
• Bergner M, Bobbitt RA, Pollard WE, The sickness impact profile: validation of a health status measure. Med Care 1976;14(1):57-67
   Google Scholar
• Potts J, Payne RE. Prostatitis: infection, neuromuscular disorder, or pain syndrome? Proper patient classification is key. Cleve Clin J Med 2007;74(Suppl 3):S63-71
   Google Scholar
• Pontari MA. Chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis: are they related? Curr Urol Rep 2006;7(4):329-34
   Google Scholar
• Propert KJ, McNaughton-Collins M, Leiby BE, A prospective study of symptoms and quality of life in men with chronic prostatitis/chronic pelvic pain syndrome: the National Institutes of Health Chronic Prostatitis Cohort study. J Urol 2006;175(2):619-23; discussion 23
   Google Scholar
• Schneider H, Wilbrandt K, Ludwig M, Prostate-related pain in patients with chronic prostatitis/chronic pelvic pain syndrome. BJU Int 2005;95(2):238-43
   Google Scholar
• Ku JH, Kim SW, Paick JS. Epidemiologic risk factors for chronic prostatitis. Int J Androl 2005;28(6):317-27
   Google Scholar
• McNaughton Collins M, MacDonald R, Wilt TJ. Diagnosis and treatment of chronic abacterial prostatitis: a systematic review. Ann Intern Med 2000;133(5):367-81
   Google Scholar
• Nickel JC, Xiang J. Clinical significance of nontraditional bacterial uropathogens in the management of chronic prostatitis. J Urol 2008;179(4):1391-5
   Google Scholar
• Nickel J. Chronic prostatitis/chronic pelvic pain syndrome: a decade of change. AUA Update Series 2006;25:309-16
   Google Scholar
• Nickel JC, Shoskes D, Wang Y, How does the pre-massage and post-massage 2-glass test compare to the Meares-Stamey 4-glass test in men with chronic prostatitis/chronic pelvic pain syndrome? J Urol 2006;176(1):119-24
   Google Scholar
• Nickel JC, Alexander RB, Schaeffer AJ, Leukocytes and bacteria in men with chronic prostatitis/chronic pelvic pain syndrome compared to asymptomatic controls. J Urol 2003;170(3):818-22
   Google Scholar
• Nadler RB, Collins MM, Propert KJ, Prostate-specific antigen test in diagnostic evaluation of chronic prostatitis/chronic pelvic pain syndrome. Urology 2006;67(2):337-42
   Google Scholar
• Nadler RB, Rubenstein JN. Laparoscopic excision of a seminal vesicle for the chronic pelvic pain syndrome. J Urol 2001;166(6):2293-4
   Google Scholar
• Propert KJ, Litwin MS, Wang Y, Responsiveness of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI). Qual Life Res 2006;15(2):299-305
   Google Scholar
• Turner JA, Ciol MA, Von Korff M, Berger R. Validity and responsiveness of the national institutes of health chronic prostatitis symptom index. J Urol 2003;169(2):580-3
   Google Scholar
• Litwin MS, McNaughton-Collins M, Fowler FJ Jr, The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol 1999;162(2):369-75
   Google Scholar
• Shoskes DA, Hakim L, Ghoniem G, Jackson CL. Long-term results of multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome. J Urol 2003;169(4):1406-10
   Google Scholar
• Nickel JC, Downey J, Johnston B, Clark J. Predictors of patient response to antibiotic therapy for the chronic prostatitis/chronic pelvic pain syndrome: a prospective multicenter clinical trial. J Urol 2001;165(5):1539-44
   Google Scholar
• Nickel JC, Narayan P, McKay J, Doyle C. Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial. J Urol 2004;171(4):1594-7
   Google Scholar
• Cheah PY, Liong ML, Yuen KH, Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial. J Urol 2003;169(2):592-6
   Google Scholar
• Mehik A, Alas P, Nickel JC, Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study. Urology 2003;62(3):425-9
   Google Scholar
• Lee SW, Liong ML, Yuen KH, Chronic prostatitis/chronic pelvic pain syndrome: role of alpha blocker therapy. Urol Int 2007;78(2):97-105
   Google Scholar
• Nickel JC, Krieger JN, McNaughton-Collins M, Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome. N Engl J Med 2008;359(25):2663-73
   Google Scholar
• Nickel JC. The Pre and Post Massage Test (PPMT): a simple screen for prostatitis. Tech Urol 1997 Spring;3(1):38-43
   Google Scholar
• Nickel JC, Pontari M, Moon T, A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis. J Urol 2003;169(4):1401-5
   Google Scholar
• Goldmeier D, Madden P, McKenna M, Tamm N. Treatment of category III A prostatitis with zafirlukast: a randomized controlled feasibility study. Int J STD AIDS 2005;16(3):196-200
   Google Scholar
• Nickel JC, Downey J, Pontari MA, A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis). BJU Int 2004;93(7):991-5
   Google Scholar
• Schaeffer A. Advances in the diagnosis and treatment of prostatitis. Urology 2002;60(6A):1-44
   Google Scholar
• Nickel JC, Forrest JB, Tomera K, Pentosan polysulfate sodium therapy for men with chronic pelvic pain syndrome: a multicenter, randomized, placebo controlled study. J Urol 2005;173(4):1252-5
   Google Scholar
• Wagenlehner FM, Schneider H, Ludwig M, A pollen extract (Cernilton) in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome: a multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study. Eur Urol 2009;56(3):544-51
   Google Scholar
• Shoskes DA, Zeitlin SI, Shahed A, Rajfer J. Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial. Urology 1999;54(6):960-3
   Google Scholar
• Giannarini G, Autorino R. Re: serenoa repens associated with Urtica dioica (ProstaMEV) and curcumin and quercitin (FlogMEV) extracts are able to improve the efficacy of prulifloxacin in bacterial prostatitis patients: results from a prospective randomised study. Int J Antimicrob Agents 2009;34(3):283-4
   Google Scholar
• Kaplan SA, Volpe MA, Te AE. A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome. J Urol 2004;171(1):284-8
   Google Scholar
• Kabay S, Kabay SC, Yucel M, Ozden H. Efficiency of posterior tibial nerve stimulation in category IIIB chronic prostatitis/chronic pelvic pain: a Sham-Controlled Comparative Study. Urol Int 2009;83(1):33-8
   Google Scholar
• Cornel EB, van Haarst EP, Schaarsberg RW, Geels J. The effect of biofeedback physical therapy in men with Chronic Pelvic Pain Syndrome Type III. Eur Urol 2005;47(5):607-11
   Google Scholar
• Ye ZQ, Cai D, Lan RZ, Biofeedback therapy for chronic pelvic pain syndrome. Asian J Androl 2003;5(2):155-8
   Google Scholar
• Anderson RU, Sawyer T, Wise D, Painful myofascial trigger points and pain sites in men with chronic prostatitis/chronic pelvic pain syndrome. J Urol 2009;182(6):2753-8
   Google Scholar
• Shoskes DA, Nickel JC, Dolinga R, Prots D. Clinical phenotyping of patients with chronic prostatitis/chronic pelvic pain syndrome and correlation with symptom severity. Urology 2009;73(3):538-42; discussion 42-3
   Google Scholar